ANNA TEOTICO: Open Payments
NPI 1629288725 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 21 payments from 14 companies in 2025. Trend: 2023 $924 · 2024 $1,230 · 2025 $710
Food & beverage: $439Education: $271
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $193 |
| BeOne Medicines USA, Inc. | 4 | $108 |
| ABBVIE INC. | 2 | $96 |
| Daiichi Sankyo Inc. | 3 | $76 |
| PFIZER INC. | 1 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Genmab U.S., Inc. | 1 | $30 |
| BeiGene USA, Inc. | 1 | $27 |
| Kite Pharma, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: BRUKINSA, IMBRUVICA, Vanflyta, EPKINLY, TIVDAK, Fabhalta, Yescarta, CALQUENCE.
Industry payments across CA — which companies pay providers there.
